Microfluidizer Á¾ÇÕÄ«´Ù·Î±×


Phone
  ´ëÇ¥ÀüÈ­ 1577-7956  
  º»     »ç 031-457-9187  
  ´ë     Àü 042-932-1265

Web Site Visitors
  Today 632    
  Yesterday 763    
  Since 2006 1,742,571    


| ¸®½ºÆ®µ¹¾Æ°¡±â |

2022³â 9¿ù 16ÀÏ ¹Ì±¹ Microfluidics »ç´Â Â÷¼¼´ë mRNA ¹ÙÀÌ¿À ÀǾàÇ° °³¹ß·Î À¯¸íÇÑ ¹Ì±¹ HDT Bio »ç¿Í °øµ¿À¸·Î Joint Webinar ¸¦ °³ÃÖÇÏ¿´½À´Ï´Ù.



¹ßÇ¥ÀÚ´Â HDT Bio »çÀÇ Dr. Darrick Carter ·Î¼­ mRNA ±â¹ÝÀÇ ¹ÙÀÌ¿À ÀǾàÇ° °³¹ßÀ» À§ÇÑ ±Ù¿ø ±â¼úÀÎ LION¢â RNA Delivery System °³¹ßÀڷμ­ À̹ø webinar ¸¦ ÅëÇØ Â÷¼¼´ë RNA Technology ¿Í Delivery System ¿¡ °üÇØ ±í°í ´Ù¾çÇÑ Áö½ÄÀ» ¹ßÇ¥ÇÏ¿´½À´Ï´Ù.


      LION¢â RNA Delivery System



¿©±â¼­´Â ÀÌÇظ¦ µ½±â À§ÇØ ÀÚ¸·À» Æ÷ÇÔÇÏ´Â webinar ¹ßÇ¥ µ¿¿µ»óÀ» ¼Ò°³ÇØ µå¸®°í ÀÖ½À´Ï´Ù.

ÁÖ     Á¦ : A Scalable Solution for Next-Generation RNA Technology and Delivery
¹ß Ç¥ ÀÚ : Dr. Darrick Carter (HDT Bio)
¹ßÇ¥³»¿ë :
¡Ü Addressing stability issues and dosing coordination learned whilst delivering the newly developed saRNA Covid-19 vaccine
¡Ü How to overcome drug delivery challenges
¡Ü Future opportunities with RNA technology in the area of infectious disease and cancer therapeutics
¡Ü How to replicate results from research & development to production scale while maintaining consistent, repeatable results
¡Ü cGMP considerations to bear in mind when selecting equipment.













 
(ÁÖ)¿µÁøÄÚÆÛ·¹ÀÌ¼Ç   |   ´ëÇ¥ : ÀÌÇü¿­   |   »ç¾÷ÀÚµî·Ï¹øÈ£ : 138-81-34745
±º Æ÷ º» »ç   |   (15853) °æ±âµµ ±ºÆ÷½Ã ÇѼ¼·Î 48 ³²¿øºôµù 2Ãþ   |   ÀüÈ­ : 1577-7956 (1)   |   Æѽº : 031-457-9188   |   À̸ÞÀÏ : info@yjcorp.co.kr
´ë Àü Áö »ç   |   (34036) ´ëÀü½Ã À¯¼º±¸ Å×Å©³ë10·Î 29 ÆÄÅ©ÆÓ¸®½º 2Ãþ   |   ÀüÈ­ : 1577-7956 (2)   |   Æѽº : 042-932-1266   |   À̸ÞÀÏ : info@yjcorp.co.kr